With permission from the patient to share, this interview highlights his journey in exploring surgical options for mitral valve repair surgery. Our discussion emphasizes the significance of patients conducting thorough research, which includes obtaining second opinions, requesting outcomes data, and reviewing publicly available quality report cards on heart programs and surgeons. The patient is currently on postoperative day three following mitral valve repair surgery performed using conventiona

The Tendyne™ transcatheter mitral valve replacement (#TMVR) system has received FDA approval in the U.S.! 🇺🇸 This innovative, minimally invasive treatment uses a #Transapical approach, offering new hope for patients with severe mitral annular calcification (MAC) who aren’t candidates for surgery or repair. ❤️🫀 #Tendyne #MitralValve #HeartHealth #FDAApproved #MinimallyInvasive #Cardiology #StructuralHeart | Abdallah Othman

FDA has approved the Edwards Sapien M3 Transcatheter Mitral Valve Replacement System for prohibitive-risk patients with severe mitral regurgitation. This transseptally delivered system offers a true valve replacement option, supported by the ENCIRCLE trial data demonstrating significant MR reduction and improved outcomes. #FDA #MedicalDevice #Cardiology #StructuralHeart #MitralValve TMVR SapienM3 ENCIRCLETrial | Abdallah Othman

The DMC cardiovascular team replaced Dontae’s mitral valve using a minimally invasive procedure, resulting in smaller incisions, less pain and a quicker recovery. Watch Dontae’s story and see how this minimally invasive technique gave him a second chance at life. #DMCHasHeart | Detroit Medical Center